Pre-extensively and extensively drug-resistant tuberculosis, in Libreville, Gabon

被引:0
|
作者
Kombila, U. D. [1 ,3 ]
Boulingui, C. Manomba [2 ,3 ]
N'Gomanda, F. [1 ]
Mavoungou, J. V. Mouity [1 ]
Epossi, C. B. H. Ngea [1 ]
Bivigou, N. [1 ]
Tsioukaka, S. [1 ]
Tshisekedi, J. D. D. [4 ]
Mahoumbou, J. [4 ]
Boguikouma, J. B. [4 ]
机构
[1] Univ Sci Sante Libreville, CHU Libreville, Fac med, Serv med interne, Libreville, Gabon
[2] CHU Libreville, Serv infectiol, Libreville, Gabon
[3] Univ Sci Sante Libreville, Fac med, Libreville, Gabon
[4] Programme Natl TB PNLT, Libreville, Gabon
关键词
Tuberculosis; Drug resistance; Extensively drug-resistant; Libreville; MULTIDRUG-RESISTANT; XDR;
D O I
10.1016/j.rmr.2024.06.011
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction. - Very few studies have been devoted to extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) in Gabon. Aim. - The aim of the present study is to present the epidemiology of pre-XDR and XDR TB and the evolution over time of patients with multidrug-resistant TB. Methods. - This retrospective study covered the activities from 2019 to 2022 of the Nkembo anti-tuberculosis center. Results. - Fifteen patients were eligible, including 11 (73.3%) pre-XDR patients and 4 (26.7%) XDR-TB patients. Three (20.0%) patients had HIV/TB co-infection. The sample consisted of 7 men (46.7%) and 8 women (53.3%), a sex ratio (M/F) of 0.87. The average age was 35.6 years, and the median 34 years, with extremes of 23 and 60 years. Eight patients (53.3%) represented new cases of pre-XDR or XDR-TB tuberculosis. The majority (60%; n = 9) came from deprived neighborhoods with widespread promiscuity. The therapeutic success rate among preXDR patients was 4 (36.4%) versus 2 (50.0%) among XDR-TB patients. Reported mortality occurred 5 (33.3%) patients during treatment, including 3 pre-XDR and 2 XDR-TB patients. In all cases, they died before the end of the first trimester of follow-up. Conclusion. - The high frequency of primary pre-extensively drug-resistant tuberculosis underscores the pervasiveness of resistance to anti-tuberculosis drugs and underlines a pressing need for detection of contact cases and early treatment. (c) 2024 SPLF. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:542 / 548
页数:7
相关论文
共 50 条
  • [1] Detection of pre-extensively drug-resistant tuberculosis by molecular testing
    Yeung, Eugene Y. H.
    Werry, Denise
    Wong, Patrick H. P.
    Mirzanejad, Yazdan
    Sekirov, Inna
    Connors, William J. A.
    Purych, Dale
    Masud, Shazia
    BRITISH COLUMBIA MEDICAL JOURNAL, 2023, 65 (09): : 340 - 344
  • [2] Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates
    Disratthakit, Areeya
    Prammananan, Therdsak
    Tribuddharat, Chanwit
    Thaipisuttikul, Iyarit
    Doi, Norio
    Leechawengwongs, Manoon
    Chaiprasert, Angkana
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5189 - 5197
  • [3] Frequency of Pre-Extensively Drug Resistant Tuberculosis and Extensively Drug Resistant Tuberculosis in Patients with Multi Drug Resistant Tuberculosis
    Ullah, Bashir
    Saboor, Rukhsana
    Iqbal, Muhammad Zahid
    Bhatti, Atiq Ahmad
    Rehman, Abad Ur
    Akram, Muhammad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (05): : 959 - 961
  • [4] Pre-extensively drug-resistant and extensively drug-resistant tuberculosis in Latin America and the Caribbean: A systematic review and meta-analysis
    Alarcon-Braga, Esteban A.
    Salazar-Valdivia, Farley E.
    Estrada-Grossmann, Jose M.
    Mendez-Guerra, Carolina
    Pacheco-Barrios, Niels
    Al-kassab-Cordova, Ali
    AMERICAN JOURNAL OF INFECTION CONTROL, 2024, 52 (03) : 349 - 357
  • [5] New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
    Viney, Kerri
    Linh, Nguyen Nhat
    Gegia, Medea
    Zignol, Matteo
    Glaziou, Philippe
    Ismail, Nazir
    Kasaeva, Tereza
    Mirzayev, Fuad
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (04)
  • [6] Susceptibility Testing of Extensively Drug-Resistant and Pre-Extensively Drug-Resistant Mycobacterium tuberculosis against Levofloxacin, Linezolid, and Amoxicillin-Clavulanate
    Ahmed, Imran
    Jabeen, Kauser
    Inayat, Raunaq
    Hasan, Rumina
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2522 - 2525
  • [7] Pre-extensively drug-resistant tuberculosis spondylodiscitis in an immunocompetent patient: a case report
    Fellous, Safaa
    Rkain, Hanan
    Tahiri, Latifa
    Bouraqadi, Amina
    Nassar, Ittimad
    Allali, Fadoua
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 7
  • [8] Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
    Padmapriyadarsini, Chandrasekaran
    Vohra, Vikram
    Bhatnagar, Anuj
    Solanki, Rajesh
    Sridhar, Rathinam
    Anande, Lalitkumar
    Muthuvijaylakshmi, M.
    Bhatia, Miraa
    Jeyadeepa, Bharathi
    Taneja, Gaurav
    Balaji, S.
    Shah, Prashant
    Saravanan, N.
    Chauhan, Vijay
    Kumar, Hemanth
    Ponnuraja, Chinnayin
    Livchits, Viktoriya
    Bahl, Monica
    Alavadi, Umesh
    Sachdeva, K. S.
    Swaminathan, Soumya
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E938 - E946
  • [9] The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia
    Shibabaw, Agumas
    Gelaw, Baye
    Gebreyes, Wondwossen
    Robinson, Richard
    Wang, Shu-Hua
    Tessema, Belay
    PLOS ONE, 2020, 15 (02):
  • [10] Pre-extensively drug-resistant tuberculosis among pulmonary multidrug-resistant tuberculosis patients in Eastern Nigeria
    Nwachukwu, Ndubuisi O.
    Ulasi, Amara E.
    Okoronkwo, Christopher U.
    Unegbu, Valentine N.
    LUNG INDIA, 2023, 40 (06) : 492 - 495